Keratoconus is a condition that can gradually affect the clarity and quality of vision. In this condition, the cornea becomes thinner and more cone-shaped than normal, leading to symptoms such as blurred vision, irregular astigmatism, and difficulty seeing at night. The condition may begin mildly, but it can progress over time if it is not properly monitored and treated.With advances in ophthalmology and eye surgery, corneal cross-linking for keratoconus has become one of the most important treatment procedures aimed at strengthening the cornea and slowing or stopping the progression of the disease. The procedure works by using riboflavin and ultraviolet (UV) light to strengthen the bonds between collagen fibers within the cornea, helping increase its rigidity and maintain its stability.In this article from Dalili Medical, we will explore keratoconus, including its causes, symptoms, and diagnostic methods. We will also discuss when a patient may need corneal cross-linking, the different types of the procedure, how it is performed, potential complications, and the most important tips for prevention and long-term follow-up.
Corneal cross-linking, medically known as Corneal Cross-Linking (CXL), is a therapeutic procedure designed to strengthen the collagen fibers within the cornea. It uses riboflavin (vitamin B2) in combination with ultraviolet A (UVA) light. The primary goal of this procedure is to stop or slow the progression of keratoconus and limit further corneal steepening and weakening.
Corneal cross-linking is not considered a definitive treatment that restores the cornea to its normal shape. Instead, its primary purpose is to stop or slow disease progression and maintain corneal stability. After cross-linking, the patient may still need to wear glasses or contact lenses to achieve better visual acuity.
Not necessarily. If keratoconus is stable and there are no signs of progression, the doctor may recommend regular monitoring and the necessary eye examinations. However, if tests show progressive corneal steepening or thinning, the doctor may recommend corneal cross-linking to help prevent further progression.
The procedure is usually performed using local anesthetic eye drops, so patients generally do not experience significant pain during the procedure. However, after treatment—particularly when the epithelium-off (Epi-off) technique is used—the patient may experience pain, burning, light sensitivity, and increased tearing during the first few days. These symptoms gradually improve as the corneal surface heals and according to the doctor’s instructions.
The duration of corneal cross-linking varies depending on the treatment protocol and device used. Traditional cross-linking generally takes longer than some accelerated protocols. The doctor determines the most appropriate technique and treatment duration based on the condition of the cornea and the patient’s individual needs.
Vision may be blurry or unstable during the initial period following the procedure. It generally improves gradually as the cornea heals and stabilizes. Achieving stable vision may take several weeks or months, depending on the individual patient and the technique used.
Yes. Patients may continue to need glasses or contact lenses after corneal cross-linking. The primary purpose of cross-linking is to slow the progression of keratoconus and maintain corneal stability, rather than directly correcting nearsightedness or astigmatism.
Yes. Many patients can return to wearing contact lenses after the procedure. However, they should wait until the corneal surface has healed sufficiently. The ophthalmologist will determine the appropriate time to resume contact lens wear based on the condition of the eye and the rate of recovery.
No. Not every patient is a suitable candidate for corneal cross-linking. The doctor needs to evaluate the corneal thickness, shape, severity of keratoconus, and evidence of disease progression before deciding whether the procedure is appropriate. Some cases involving severe corneal thinning or very advanced keratoconus may require other treatment options.
Epi-off technique:
The surface layer of the cornea, known as the epithelium, is removed before applying riboflavin and treating the cornea with ultraviolet A (UVA) light. This technique is among the most extensively studied and widely used corneal cross-linking methods.
Epi-on technique:
The cross-linking procedure is performed without removing the corneal epithelium. This may help reduce discomfort and shorten the recovery of the corneal surface. However, the effectiveness of this technique varies depending on the specific protocol used. Therefore, the ophthalmologist determines the most appropriate technique based on the patient’s corneal condition.
No. It is not possible to guarantee that keratoconus progression will be stopped 100% in every case. The goal of cross-linking is to stop or slow disease progression and maintain corneal stability. Therefore, regular follow-up remains important even after the procedure to ensure that the cornea remains stable.
If the other eye is also affected by keratoconus, this does not necessarily mean that it requires cross-linking. The doctor determines whether treatment is needed based on examination results and actual evidence of disease progression, rather than simply because keratoconus is present in the other eye.
Some patients may notice an improvement in visual quality after corneal cross-linking. However, improving visual acuity is not the primary goal of the procedure. The main objective is to strengthen the cornea and slow or stop the progression of keratoconus. Patients may still need glasses or contact lenses to achieve better vision.
The time required to return to work or school varies depending on the cross-linking technique used, the nature of the patient’s work, and the rate of corneal surface healing. With the Epi-off technique, patients may need several days of rest, while surface recovery may be shorter with some Epi-on techniques. The ophthalmologist will determine when it is appropriate to resume daily activities based on the condition of the eye.
Patients are generally advised to avoid sports and physical activities that may expose the eye to impact, rubbing, dust, or sweat during the recovery period. You should consult your ophthalmologist before returning to exercise, especially when participating in contact sports or activities that carry a risk of eye injury.
No. Eye rubbing should be completely avoided, both before and after corneal cross-linking, and this is especially important while the cornea is healing. Any eye allergy or itching should also be properly treated to reduce the urge to rub the eyes.
Yes. Regular follow-up is important for maintaining corneal health and monitoring its stability, even after corneal cross-linking. Follow-up may include a comprehensive eye examination, visual acuity testing, and corneal imaging using Pentacam or corneal Topography/Tomography. The results are compared with previous examinations to detect any early changes in the cornea.
Corneal Cross-Linking (CXL) is one of the most important procedures used in the management of keratoconus. Its primary purpose is to strengthen the corneal tissue and stop or slow disease progression, rather than directly improving visual acuity.
Documented progression of keratoconus:
Progression may be identified by comparing corneal examination results over time and detecting an increase in corneal steepening or changes in parameters such as Kmax.
Increasing myopia or astigmatism:
A significant and repeated increase in nearsightedness or astigmatism during follow-up may indicate ongoing changes in the shape of the cornea.
Changes in corneal maps:
Changes detected on Pentacam or Topography/Tomography may provide evidence that keratoconus is progressing.
Declining visual quality:
A deterioration in vision despite using appropriate glasses or contact lenses may be considered, particularly when accompanied by other findings that confirm corneal progression.
Evidence of active disease progression:
Keratoconus may be in an early or moderate stage but continue to change over time. In such cases, corneal cross-linking may be an appropriate treatment option.
Higher risk of disease progression:
In some patients, the ophthalmologist may recommend cross-linking at an earlier stage, particularly in younger patients, after evaluating corneal shape, thickness, and examination results.
With the commonly used Epi-off protocol, the procedure generally involves the following steps:
Other techniques are also available, including Epi-on corneal cross-linking, which does not involve removing the epithelium, as well as various accelerated cross-linking protocols.
The severity of keratoconus varies from one patient to another. The condition may progress from mild changes in the shape of the cornea to significant corneal thinning and steepening.
One of the traditional classifications used to describe keratoconus severity is the Amsler-Krumeich classification, which divides keratoconus into four main stages.
| Stage | Corneal Changes | Effect on Vision | Potential Treatment Options |
|---|---|---|---|
| Stage 1 – Mild | Mild changes in corneal shape and refraction, with early irregularity of the corneal surface | Limited effect on visual clarity | Glasses and regular monitoring; cross-linking may be performed if progression is confirmed |
| Stage 2 – Moderate | Increased corneal steepening and thinning, with greater surface irregularity | Increased blurred vision and astigmatism | Specialized contact lenses, with cross-linking when disease progression is present |
| Stage 3 – Advanced | More pronounced corneal thinning and steepening, with possible corneal changes or opacities | Significant reduction in visual quality | Cross-linking when appropriate, specialized contact lenses, and evaluation of surgical options when necessary |
| Stage 4 – Severe | Severe thinning and advanced steepening, sometimes accompanied by corneal scarring or extensive opacities | Severe visual impairment | Corneal transplantation may be an appropriate option in some advanced cases |
The Epi-off technique is one of the most widely used and extensively studied corneal cross-linking protocols.
With the Epi-on or transepithelial technique, the corneal epithelium is not removed. Instead, a specific protocol is used to facilitate the penetration of riboflavin into the cornea, followed by exposure to UVA light.
The corneal epithelium acts as a barrier to the penetration of riboflavin into the corneal tissue. Therefore, the effectiveness of this technique may vary depending on the protocol and device used, and its outcomes may not always be equivalent to those of epithelium-off cross-linking.
Accelerated corneal cross-linking uses higher-intensity ultraviolet (UV) light with a shorter exposure time compared with some conventional protocols.
The goal is to reduce the duration of the procedure while maintaining an appropriate therapeutic dose.
However, increasing UV intensity and reducing exposure time does not necessarily mean that all accelerated protocols are equivalent to conventional cross-linking in terms of outcomes. Effectiveness varies depending on the dose and specific protocol used.
This approach combines:
This may help shorten the recovery period. However, the ability of riboflavin to penetrate the corneal epithelium remains an important factor affecting treatment effectiveness.
In some specialized techniques, the treatment pattern can be modified according to the corneal shape and Topography or Tomography maps.
The concept is to treat the cornea according to the characteristics of its different areas rather than applying the same treatment uniformly across the entire cornea.
These techniques are more specialized and may not be available at all centers. Their use depends on the patient’s condition and the available treatment protocol.
In some cases, the goal is not only to stop disease progression but also to improve corneal regularity and visual quality. Therefore, corneal cross-linking may be combined with other procedures.
Intracorneal ring segments are small implants placed within the layers of the cornea to help modify its shape and reduce corneal irregularity.
Each procedure has a different role:
The two procedures may be combined in selected cases.
In highly selected cases, topography-guided or customized PRK may be used to improve the regularity of the corneal surface, followed by corneal cross-linking to help stabilize the treatment result.
This approach requires careful patient selection, particularly regarding corneal thickness and shape.
After the cornea has stabilized, patients may still require specialized contact lenses, such as rigid gas-permeable (RGP) or scleral lenses, to improve vision.
It is important to note that contact lenses do not strengthen the cornea or stop the progression of keratoconus. Their primary role is to improve visual quality.
Blurred vision is one of the common symptoms of keratoconus and may appear as:
One of the important signs of keratoconus is the presence of irregular astigmatism or a gradual increase in its severity. Patients may notice that glasses that previously provided clear vision no longer provide the same level of visual clarity.
Patients may need to change their glasses prescription frequently because of continued changes in corneal shape. This can result in changes in the degree of myopia and astigmatism.
Patients may notice, particularly when viewing with one eye:
Halos or bright rings around lights may appear and are often more noticeable at night. This can make nighttime driving more difficult.
Vision may become more difficult in low-light conditions. Patients may have difficulty distinguishing details or seeing lights clearly at night.
Some patients may experience increased sensitivity to light, which may be accompanied by discomfort or increased tearing.
An irregular corneal surface can cause eye strain as the patient attempts to maintain focus. Symptoms may include:
Some patients may experience itchy eyes, particularly when they have allergies, which can lead to frequent eye rubbing.
Forceful or repeated eye rubbing should be avoided, as it may be associated with worsening keratoconus in some patients. Treating the underlying causes of itching and allergies is therefore recommended instead of rubbing the eyes.
As keratoconus progresses, glasses may no longer provide adequate visual correction. The patient may then require specialized contact lenses, such as rigid gas-permeable or scleral lenses, to achieve better vision.
Prescription glasses are commonly used in the early stages of keratoconus, particularly when the astigmatism is relatively regular and can be adequately corrected.
Glasses can help:
However, glasses do not stop the progression of keratoconus and may become insufficient as the corneal surface becomes more irregular. In such cases, the ophthalmologist may recommend specialized contact lenses or other treatment options.
When glasses do not provide adequate vision, specialized contact lenses may be used. The appropriate type of lens is selected according to the shape of the cornea and degree of irregularity.
Common types include:
It is important to emphasize that contact lenses improve vision but do not strengthen the cornea or stop the progression of keratoconus.
Corneal cross-linking is one of the most important procedures used when there is evidence of keratoconus progression.
The procedure uses riboflavin (vitamin B2) combined with ultraviolet A (UVA) light to promote additional bonds between collagen fibers within the cornea. This helps increase corneal strength and resistance to further structural changes.
The main techniques include:
The primary goal of cross-linking is to stop or slow the progression of keratoconus, rather than directly correcting myopia or astigmatism.
Intracorneal ring segments are small implants inserted into the layers of the cornea to modify its shape and reduce corneal irregularity.
They may help:
In selected patients, intracorneal ring implantation may be combined with corneal cross-linking. The ring segments aim to modify the shape of the cornea, while cross-linking aims to strengthen it and slow disease progression.
In some patients, procedures such as topography-guided PRK may be considered to improve corneal surface regularity. Corneal cross-linking may be performed in conjunction with the procedure in selected cases.
However, these procedures are not suitable for all patients with keratoconus. Careful evaluation of corneal thickness, shape, and disease severity is required because preserving healthy corneal tissue is essential.
Corneal transplantation may be considered for very advanced cases in which glasses, contact lenses, or other procedures no longer provide functional vision, or when significant corneal scarring or opacity is present.
Types of corneal transplantation include:
To maintain corneal health and reduce the risk of keratoconus progression, patients are advised to follow several important recommendations:
What's your complaint?